Abstract:The onset of obesity-linked type 2 diabetes (T2D) is marked by an eventual failure in pancreatic β-cell function and mass that is no longer able to compensate for the inherent insulin resistance and increased metabolic load intrinsic to obesity. However, in a commonly used model of T2D, the db/db mouse, β-cells have an inbuilt adaptive flexibility enabling them to effectively adjust insulin production rates relative to the metabolic demand. Pancreatic β-cells from these animals have markedly reduced intracellular insulin stores, yet high rates of (pro)insulin secretion, together with a substantial increase in proinsulin biosynthesis highlighted by expanded rough endoplasmic reticulum and Golgi apparatus. However, when the metabolic overload and/or hyperglycemia is normalized, β-cells from db/db mice quickly restore their insulin stores and normalize secretory function. This demonstrates the β-cell's adaptive flexibility and indicates that therapeutic approaches applied to encourage β-cell rest are capable of restoring endogenous β-cell function. However, mechanisms that regulate β-cell adaptive flexibility are essentially unknown. To gain deeper mechanistic insight into the molecular events underlying β-cell adaptive flexibility in db/db β-cells, we conducted a combined proteomic and post-translational modification specific proteomic (PTMomics) approach on islets from db/db mice and wild-type controls (WT) with or without prior exposure to normal glucose levels. We identified differential modifications of proteins involved in redox homeostasis, protein refolding, K48-linked deubiquitination, mRNA/protein export, focal adhesion, ERK1/2 signaling, and renin-angiotensin-aldosterone signaling, as well as sialyltransferase activity, associated with β-cell adaptive flexibility. These proteins are all related to proinsulin biosynthesis and processing, maturation of insulin secretory granules, and vesicular trafficking-core pathways involved in the adaptation of insulin production to meet metabolic demand. Collectively, this study outlines a novel and comprehensive global PTMome signaling map that highlights important molecular mechanisms related to the adaptive flexibility of β-cell function, providing improved insight into disease pathogenesis of T2D.

Pancreatic Brsk2 Amplifies Parasympathetic Signals to Promote Type 2 Diabetes

BRSK2 in Pancreatic Β Cells Promotes Hyperinsulinemia-Coupled Insulin Resistance and Its Genetic Variants Are Associated with Human Type 2 Diabetes.

Brain-selective Kinase 2 (BRSK2) Phosphorylation on PCTAIRE1 Negatively Regulates Glucose-Stimulated Insulin Secretion in Pancreatic Β-Cells.

DRAK2 Suppresses Autophagy by Phosphorylating ULK1 at Ser56 to Diminish Pancreatic Β Cell Function Upon Overnutrition.

Brd2 disruption in mice causes severe obesity without Type 2 diabetes

cNPAS2 induced β cell dysfunction by regulating KANK1 expression in type 2 diabetes

The Constitutive Activation of Egr-1/C/EBPa Mediates the Development of Type 2 Diabetes Mellitus by Enhancing Hepatic Gluconeogenesis

Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic β cells and liver.

Sphingosine Kinase 2 Promotes Lipotoxicity in Pancreatic Β‐cells and the Progression of Diabetes

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus

KSRP improves pancreatic beta cell function and survival

Reversal of angiotensin ll-induced β-cell dedifferentiation via inhibition of NF-κb signaling

SAA1 exacerbates pancreatic β-cell dysfunction through activation of NF-κB signaling in high-fat diet-induced type 2 diabetes mice

Bromodomain-containing protein 2 induces insulin resistance via the mTOR/Akt signaling pathway and an inflammatory response in adipose tissue

Pathological Roles of Bone Marrow Adipocyte-Derived Monocyte Chemotactic Protein-1 in Type 2 Diabetic Mice

SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice

Zhx2 Maintains Islet Β-Cell Mass and Function by Transcriptionally Regulating Pax6.

KCa3.1 Channel Mediates Inflammatory Signaling of Pancreatic Β Cells and Progression of Type 2 Diabetes Mellitus

DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser 56 to diminish pancreatic β cell function upon overnutrition

Pancreatic progenitor epigenome maps prioritize type 2 diabetes risk genes with roles in development